Fate Therapeutics's total assets for Q1 2025 were $398.67M, a decrease of -9.54% from the previous quarter. FATE total liabilities were $110.26M for the fiscal quarter, a -9.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.